The University Hospital Bonn plans to have a stronger focus on pharmacogenetics – thus emphasising the influence of genetic characteristics on the effect of medications. This idea embodies the approach for personalised medicine. To integrate extensive pharmacogenetic analysis into the clinical workflow, the Institute of Human Genetics at the University Hospital Bonn and HMG Systems Engineering GmbH (HMG) are establishing a partnership. The intended purpose is to provide the treating physician with clinically relevant information regarding pharmacologic and genetic interaction risks. That way, physicians are empowered to optimize the individual drug therapy for each patient.
Each human metabolises medication differently. Similar to the diverse factors forming diseases, the influences on the effect and tolerance of the prescribed medicine tend to be multifaceted. In addition to the age, weight, lifestyle and nutrition habits, and the intake of further medicines, patients’ genetic characteristics also impact the desired therapeutic effect.
In consideration of selected characteristics in the genome, pharmacogenetics enables an individual optimisation of the medication. Thus, patient-related risks and side effects can be reduced.
"The development of personalised therapies is making great progress."
"The pharmacogenetic profile of a patient can be critical in determining an optimal medication. Especially when several drugs are prescribed and interactions between them are to be expected," says Prof. Dr. Markus Nöthen, director of the Institute for Human Genetics at the University Hospital Bonn.
With its scientific working groups, it contributes to the research of the genetic causes of diseases and to the development of effective, individually tailored drug therapies and preventive measures.
“The partnership will enable us to use the innovative software and database developed by HMG and to introduce high-level pharmacogenetic diagnostics. In addition, a pilot project for patients at the University Hospital Bonn will be developed in the coming months. It is our vision that patients at our clinic benefit from the latest scientific knowledge in genetic medicine," says Prof. Nöthen.
“The future of medical technology is personalised medicine”
HMG has developed an IT platform, which interprets clinically relevant genetic information of the patient and its influences on individual drug metabolism. The software consists of own pharmacogenetic database. Considering 173 genetic variations, it constitutes the current state of research and is based upon up-to-date findings of science.
The database is complemented by a drug interactions check, evaluating the interactions of 40,000 drugs and 60 food and beverages. This enables physicians to optimise the patient’s medication in an even more precise, safe and efficient way.
“We are convinced that this medical technology will prospectively provide the appropriate drug with the right dose at the right time for each patient. We are delighted to partner with the renowned Institute of Human Genetics at the University Hospital Bonn and Prof. Markus Nöthen. Together we are taking a major step to translate pharmacogenetics basic research to clinical routine and medical prescription,” says Herna Muñoz-Galeano, founder and managing director of HMG Systems Engineering GmbH.
For more information about the Institute of Human Genetics at the University Hospital Bonn:
For more information about HMG Systems Engineering GmbH:
Prof. Dr. Markus Nöthen
Director of the Institute of Human Genetics
University Hospital Bonn
Telefon: 0228/ 287-51100
Managing director HMG Systems Engineering GmbH
Marketing & Communikations
HMG Systems Engineering GmbH
Telefon: 0911/ 97 91 08 57
Johannes Seiler | idw - Informationsdienst Wissenschaft
New 'jumping' superbug gene discovered, resistant to last-resort antibiotic
08.05.2019 | Cornell University
Improving the well-being of heart-failure patients
06.05.2019 | Julius-Maximilians-Universität Würzburg
The demands placed on a dental prosthesis are high: it should look natural, endure accidental biting on cherry pits – and if possible, the patient should be...
Researchers from the Universities of Münster (Germany), Oxford and Exeter (both UK) have succeeded in developing a piece of hardware which could pave the way for creating computers which resemble the human brain. The scientists produced a chip containing a network of artificial neurons that works with light and can imitate the behaviour of neurons and their synapses. The network is able to “learn” information and use this as a basis for computing and recognizing patterns. As the system functions solely with light and not with electrons, it can process data many times faster than traditional systems. The study is published in “Nature”.
A technology that functions like a brain? In these times of artificial intelligence, this no longer seems so far-fetched - for example, when a mobile phone can...
An international collaboration with participation of the University of Bern has demonstrated for the first time in an interference experiment that antimatter particles also behave as waves besides having particle properties. This success paves the way to a new field of investigations of antimatter.
Matter waves constitute a crucial feature of quantum mechanics, where particles have wave properties in addition to particle characteristics. This...
A photodetector converts light into an electrical signal, causing the light to be lost. Researchers led by Tracy Northup at the University of Innsbruck have now built a quantum sensor that can measure light particles non-destructively. It can be used to further investigate the quantum properties of light.
Physicist Tracy Northup is currently researching the development of quantum internet at the University of Innsbruck. The American citizen builds interfaces...
It is only an inconspicuous piece of paper, but it is an important milestone for autonomous driving: At the end of 2018 the three partners from the joint research project RadarGlass applied for a patent for an innovative radar system. The Fraunhofer Institute for Laser Technology ILT from Aachen, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP from Dresden and the Institute of High Frequency Technology IHF of RWTH Aachen University have developed a coating process chain that enables radar sensors to be integrated in car headlights. After almost two years in development they have manufactured a working prototype.
Completely autonomous vehicles pose an enormous challenge for sensor technology because, in principle, the supporting system must hear, see and feel better...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
13.05.2019 | Information Technology
13.05.2019 | Materials Sciences
13.05.2019 | Life Sciences